000			03513cam a22003254a 4500
999			_c8044 _d8044
001			12304436
003			OSt
005			20200219101509.0
008			010208s2001 enka b 001 0 eng
010			_a 2001017865
020			_a0471822116 (alk. paper)
040			_aDLC _cDLC _dDLC
042			_apcc
050	0	0	_aR853.S7 _bB49 2001
082	0	0	_a615.507 24 RED C _221
245	0	0	_aBiostatistics in clinical trials / _ceditors, Carol K. Redmond, Theodore Colton.
260			_aChichester ; _aNew York : _bWiley, _cc2001.
300			_axx, 501 p. : _bill. ; 25 cm.
440		4	_aThe Wiley reference series in biostatistics
504			_aIncludes bibliographical references and index.
505			_aAdaptive and Dynamic Methods of Treatment Assignment. Antibacterial Agent Trials. Audit and Quality Control. Bayesian Methods. Benefit/Risk Assessment. Binding or Masking. Clinical Significance Versus Statistical Significance. Clinical Trials, Overview. Cluster Randomization. Cochrane Collaboration. Community Intervention Trials. Compliance Assessment. CONSORT. Controlled Clinical Trials. Cooperative Cancer Trials. Cooperative Heart Disease Trials. Cooperative Studies Program, US Department of Veterans Affairs. Cost-effectiveness. Covariate Imbalance, Adjustment for. Crossover Designs. Data and Safety Monitoring. Data and Safety Monitoring Boards. Data Management and Coordination. Drug Approval and Regulation. Drug Interactions. Eligibility and Exclusion Criteria. Equivalence Trials. Ethics. European Federation of Statisticians in the Pharmaceutical Industry (EFPSI). European Organization for Research and Treatment of Cancer (EORTC). Factorial Designs. Fraud. Group-randomization Designs. Guidelines. Historical Controls, Bias From. History, Early Cancer and Heart Disease Trials. History, Overview. Intention-to-Treat Analysis. International Studies of Infarct Survival (ISIS). Medical Ethics and Statistics. Medical Research Council (MRC) Streptomycin Trial. Meta-analysis. Missing Data. Multicenter Trials. Multiple Endpoints. Multiplicity. Noncompliance, Adjustment for. Nonrandomized Trials. NSABP and Advances in the Treatment of Breast Cancer. Number Needed to Treat (NNT). Outcome Measures. Pharmaceutical Industry, Statistics in. Phase I Trials. Phase II Trials. Physicians' Health Study. Postmarketing Surveillance of New Drugs and Assessment of Risk. Preclinical Treatment Evaluation. Prevention Trials. Protocols. QUOROM. Randomization. Randomized Treatment Assignment. Salk Vaccine. Sample Size Determination. Screening Trials. Sequential Methods. Society for Clinical Trials. Software. Statistical Review for Medical Journals. Statistical Review for Medical Journals, Guidelines for Authors. Statisticians in the Pharmaceutical Industry (PSI). Surrogate Endpoints. Textbooks. Time-varying Treatment Effect. Treatment--Covariate Interaction. University Group Diabetes Program (UGDP). Vaccine Studies.
650		0	_aClinical trials _xStatistical methods.
700	1		_aRedmond, Carol K.
700	1		_aColton, Theodore.
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/description/wiley034/2001017865.html
856	4		_3Table of Contents _uhttp://www.loc.gov/catdir/toc/onix06/2001017865.html
906			_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg
942			_2ddc _cRFT